Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock
Close on Nov 16, 2026Market cap $4.24MP/E –Yield –
Earnings
Shuttle Pharmaceuticals's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Shuttle Pharmaceuticals's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2025ended Dec 31, 2025 | Feb 17, 2026during market hours | – | – | – | Filing |
| Q4 FY2024ended Dec 31, 2024 | Feb 26, 2025before the open | – | – | – | Filing |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024during market hours | – | – | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 14, 2024before the open | – | – | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 22, 2024before the open | – | – | – | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 14, 2023before the open | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 15, 2023before the open | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 26, 2023before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Shuttle Pharmaceuticals has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Shuttle Pharmaceuticals puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Shuttle Pharmaceuticals filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
- News
- News
- News
- News
- Update
- Update
- News
- News
- News
See a number that looks wrong?